Needham & Company Reiterates a 'Buy' on Solta Medical (SLTM); Good Quarter
Tweet
Share
E-mailGet Alerts SLTM Hot Sheet
Price: $2.92 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Solta Medical (NASDAQ: SLTM) price target of $4.00.
Analyst, Dal ton Chandler, said, "The LipoSonix body contouring device was launched in January about three months after it was acquired from Medicis (NYSE: MRX)(notrated) and it appears to be off to a very strong start. Contradicting a competitor’s earlier comments, management maintained that the ASP on the 78 new devices placed in the quarter was greater than $90 K and at better margins than the core equipment. The company also sold 11 upgrade units." (Needham lowers FY12 EPS from (0.04) to (0.17)
For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.
Shares of Solta Medical closed at $3.24 yesterday.
Analyst, Dal ton Chandler, said, "The LipoSonix body contouring device was launched in January about three months after it was acquired from Medicis (NYSE: MRX)(notrated) and it appears to be off to a very strong start. Contradicting a competitor’s earlier comments, management maintained that the ASP on the 78 new devices placed in the quarter was greater than $90 K and at better margins than the core equipment. The company also sold 11 upgrade units." (Needham lowers FY12 EPS from (0.04) to (0.17)
For an analyst ratings summary and ratings history on Solta Medical click here. For more ratings news on Solta Medical click here.
Shares of Solta Medical closed at $3.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Baby Bunting Group Ltd (BBN:AU) PT Raised to AUD1.65 at Macquarie
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
